Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aachal Kotecha

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Survey of Ophthalmology|December 6, 2007
What biomechanical properties of the cornea are relevant for the clinician?Aachal Kotecha
Clinical & Experimental Ophthalmology|October 29, 2008
The risks of being hystericalAachal Kotecha
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|February 15, 2013
Author's reply: To PMID 23009293Aachal Kotecha, Jonathan Clarke
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|December 21, 2012
Authors' replyAachal Kotecha, Jonathan Clarke
British Medical Bulletin|August 23, 2008
Visual function and fitness to driveAachal Kotecha, Alexander Spratt, Ananth Viswanathan
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|September 27, 2012
Comparison of optometrist glaucoma referrals against published guidelinesSheema Khan, Jonathan Clarke, Aachal Kotecha
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|December 21, 2012
Authors' replySheema Khan, Jonathan Clarke, Aachal Kotecha
Eye (London, England)|February 23, 2024
Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusionAndrew Chang, Aachal Kotecha, Faiz Kermani, et al.
Eye (London, England)|July 10, 2024
Infographic: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in neovascular age-related macular degeneration (pooled results from TENAYA and LUCERNE)Naomi Wijesingha, Aachal Kotecha, Philippe Margaron, et al.
The British Journal of Ophthalmology|October 11, 2015
Applanation tonometry: interobserver and prism agreement using the reusable Goldmann applanation prism and the Tonosafe disposable prismCsilla Ajtony, Ahmed Elkarmouty, Keith Barton, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Survey of Ophthalmology|December 6, 2007
What biomechanical properties of the cornea are relevant for the clinician?Aachal Kotecha
Clinical & Experimental Ophthalmology|October 29, 2008
The risks of being hystericalAachal Kotecha
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|February 15, 2013
Author's reply: To PMID 23009293Aachal Kotecha, Jonathan Clarke
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|December 21, 2012
Authors' replyAachal Kotecha, Jonathan Clarke
British Medical Bulletin|August 23, 2008
Visual function and fitness to driveAachal Kotecha, Alexander Spratt, Ananth Viswanathan
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|September 27, 2012
Comparison of optometrist glaucoma referrals against published guidelinesSheema Khan, Jonathan Clarke, Aachal Kotecha
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|December 21, 2012
Authors' replySheema Khan, Jonathan Clarke, Aachal Kotecha
Eye (London, England)|February 23, 2024
Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusionAndrew Chang, Aachal Kotecha, Faiz Kermani, et al.
Eye (London, England)|July 10, 2024
Infographic: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in neovascular age-related macular degeneration (pooled results from TENAYA and LUCERNE)Naomi Wijesingha, Aachal Kotecha, Philippe Margaron, et al.
The British Journal of Ophthalmology|October 11, 2015
Applanation tonometry: interobserver and prism agreement using the reusable Goldmann applanation prism and the Tonosafe disposable prismCsilla Ajtony, Ahmed Elkarmouty, Keith Barton, et al.
Pageof 6